Literature DB >> 9008313

Molecular cloning of two new HLA-C alleles: Cw*1801 and Cw*0706.

C Vilches1, M Bunce, L Sanz, R de Pablo, S Puente, M Kreisler.   

Abstract

Nucleotide sequence analysis of the HLA-C alleles of the GB92 cell line, heterozygous for B*8101 and B*4407, revealed the existence of two new allelic variants: Cw*1801 and Cw*0706. The former allele, initially detected as a PCR-SSP variant, displays a hybrid aspect, sharing sequence motifs with Cw*07 at exons 1 and 2, and with Cw*04 at distal exons. In serological assays, Cw*1801 is only recognized by some cross-reactive sera. Cw*0706 shows a primary structure closely related to previously known Cw7 alleles, but carries new sequence motifs at its 3'-end. Preliminary data indicate that Cw*1801 is associated to B*8101 and that Cw*0706, B*4407 could account for a part of the Cw7, B44 haplotypes observed in African populations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9008313     DOI: 10.1111/j.1399-0039.1996.tb02694.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  3 in total

1.  Characterization of the HLA-C*07:01:01G allele group in European and African-American cohorts.

Authors:  Zhihui Deng; Xiaojiang Gao; Gregory D Kirk; Steven Wolinsky; Mary Carrington
Journal:  Hum Immunol       Date:  2012-04-28       Impact factor: 2.850

2.  Treating a Multidrug-Resistant Psoriatic HLA-C*18:01 Allele Carrier with Combination Ustekinumab Apremilast Therapy.

Authors:  Marco Galluzzo; Simone D'Adamio; Elena Campione; Luca Bianchi; Marina Talamonti
Journal:  Mol Diagn Ther       Date:  2018-12       Impact factor: 4.074

3.  HLA-C*18:01: A Rare Allele in the European Caucasian Population Coinciding with Difficult-to-Treat Plaque Psoriasis.

Authors:  M Galluzzo; M Andreani; M Testi; S Chimenti; M Talamonti
Journal:  Mol Diagn Ther       Date:  2016-06       Impact factor: 4.074

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.